APOGEE ENTERPRISES, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that APOGEE ENTERPRISES, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 1, 2025 | $1.36B | Apr 24, 2025 |
| FY2025 | Mar 2, 2024 | $1.42B | Apr 24, 2025 |
| FY2025 | Feb 25, 2023 | $1.44B | Apr 24, 2025 |
| FY2024 | Feb 26, 2022 | $1.31B | Apr 26, 2024 |
| FY2023 | Feb 27, 2021 | $1.23B | Apr 21, 2023 |
| FY2019 | Feb 29, 2020 | $337.10M | Apr 24, 2020 |
| FY2019 | Nov 30, 2019 | $337.92M | Apr 24, 2020 |
| FY2019 | Aug 31, 2019 | $357.06M | Apr 24, 2020 |
| FY2019 | Jun 1, 2019 | $355.37M | Apr 24, 2020 |
| FY2019 | Mar 2, 2019 | $346.26M | Apr 24, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 1, 2025 | $1.36B | Apr 24, 2025 |
| FY2025 | Mar 2, 2024 | $1.42B | Apr 24, 2025 |
| FY2025 | Feb 25, 2023 | $1.44B | Apr 24, 2025 |
| FY2024 | Feb 26, 2022 | $1.31B | Apr 26, 2024 |
| FY2023 | Feb 27, 2021 | $1.23B | Apr 21, 2023 |
| FY2022 | Feb 29, 2020 | $1.39B | Apr 22, 2022 |
| FY2018 | Mar 2, 2019 | $346.26M | Apr 26, 2019 |
| FY2019 | Mar 3, 2018 | $1.33B | Apr 24, 2020 |
| FY2018 | Mar 4, 2017 | $1.11B | Apr 26, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Mar 3, 2018 | $353.45M | Apr 30, 2018 |
| FY2017 | Dec 2, 2017 | $356.51M | Apr 30, 2018 |
| FY2017 | Sep 2, 2017 | $343.91M | Apr 30, 2018 |
| FY2017 | Jun 3, 2017 | $272.31M | Apr 30, 2018 |
| FY2017 | Mar 4, 2017 | $314.13M | Apr 30, 2018 |
| FY2017 | Nov 26, 2016 | $274.07M | Apr 30, 2018 |
| FY2017 | Aug 27, 2016 | $278.46M | Apr 30, 2018 |
| FY2017 | May 28, 2016 | $247.88M | Apr 30, 2018 |
| FY2016 | Feb 27, 2016 | $262.15M | Apr 28, 2017 |
| FY2016 | Nov 28, 2015 | $238.32M | Apr 28, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 1, 2025 | $359.89M | Apr 24, 2025 |
| FY2025 | Mar 2, 2024 | $367.13M | Apr 24, 2025 |
| FY2025 | Feb 25, 2023 | $335.27M | Apr 24, 2025 |
| FY2024 | Feb 26, 2022 | $274.16M | Apr 26, 2024 |
| FY2023 | Feb 27, 2021 | $275.69M | Apr 21, 2023 |
| FY2019 | Feb 29, 2020 | $77.48M | Apr 24, 2020 |
| FY2019 | Nov 30, 2019 | $74.31M | Apr 24, 2020 |
| FY2019 | Aug 31, 2019 | $86.21M | Apr 24, 2020 |
| FY2019 | Jun 1, 2019 | $80.97M | Apr 24, 2020 |
| FY2019 | Mar 2, 2019 | $44.28M | Apr 24, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 1, 2025 | $85.05M | Apr 24, 2025 |
| FY2025 | Mar 2, 2024 | $99.61M | Apr 24, 2025 |
| FY2025 | Feb 25, 2023 | $104.11M | Apr 24, 2025 |
| FY2024 | Feb 26, 2022 | $3.49M | Apr 26, 2024 |
| FY2023 | Feb 27, 2021 | $15.44M | Apr 21, 2023 |
| FY2019 | Feb 29, 2020 | $11.96M | Apr 24, 2020 |
| FY2019 | Nov 30, 2019 | $15.23M | Apr 24, 2020 |
| FY2019 | Aug 31, 2019 | $19.28M | Apr 24, 2020 |
| FY2019 | Jun 1, 2019 | $15.44M | Apr 24, 2020 |
| FY2019 | Mar 2, 2019 | ($12.08M) | Apr 24, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 1, 2025 | $118.11M | Apr 24, 2025 |
| FY2025 | Mar 2, 2024 | $133.83M | Apr 24, 2025 |
| FY2025 | Feb 25, 2023 | $125.79M | Apr 24, 2025 |
| FY2024 | Feb 26, 2022 | $22.05M | Apr 26, 2024 |
| FY2023 | Feb 27, 2021 | $25.53M | Apr 21, 2023 |
| FY2022 | Feb 29, 2020 | $87.85M | Apr 22, 2022 |
| FY2018 | Mar 2, 2019 | ($14.78M) | Apr 26, 2019 |
| FY2019 | Mar 3, 2018 | $114.28M | Apr 24, 2020 |
| FY2018 | Mar 4, 2017 | $122.23M | Apr 26, 2019 |
| FY2017 | Feb 27, 2016 | $97.39M | Apr 30, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 1, 2025 | $29.00M | Apr 24, 2025 |
| FY2025 | Mar 2, 2024 | $30.30M | Apr 24, 2025 |
| FY2025 | Feb 25, 2023 | $25.50M | Apr 24, 2025 |
| FY2024 | Feb 26, 2022 | $17.30M | Apr 26, 2024 |
| FY2023 | Feb 27, 2021 | $15.30M | Apr 21, 2023 |
| FY2022 | Feb 29, 2020 | $16.60M | Apr 22, 2022 |
| FY2021 | Mar 2, 2019 | $19.50M | Apr 22, 2021 |
| FY2019 | Mar 3, 2018 | $14.00M | Apr 24, 2020 |
| FY2018 | Mar 4, 2017 | $8.60M | Apr 26, 2019 |
| FY2017 | Feb 27, 2016 | $8.00M | Apr 30, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 1, 2025 | $241.78M | Apr 24, 2025 |
| FY2025 | Mar 2, 2024 | $233.30M | Apr 24, 2025 |
| FY2025 | Feb 25, 2023 | $209.49M | Apr 24, 2025 |
| FY2024 | Feb 26, 2022 | $202.64M | Apr 26, 2024 |
| FY2023 | Feb 27, 2021 | $180.09M | Apr 21, 2023 |
| FY2022 | Feb 29, 2020 | $231.11M | Apr 22, 2022 |
| FY2018 | Mar 2, 2019 | $59.06M | Apr 26, 2019 |
| FY2019 | Mar 3, 2018 | $219.23M | Apr 24, 2020 |
| FY2018 | Mar 4, 2017 | $169.80M | Apr 26, 2019 |
| FY2017 | Feb 27, 2016 | $146.18M | Apr 30, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 1, 2025 | $125.16M | Apr 24, 2025 |
| FY2025 | Mar 2, 2024 | $204.15M | Apr 24, 2025 |
| FY2025 | Feb 25, 2023 | $102.70M | Apr 24, 2025 |
| FY2024 | Feb 26, 2022 | $100.47M | Apr 26, 2024 |
| FY2023 | Feb 27, 2021 | $141.86M | Apr 21, 2023 |
| FY2022 | Feb 29, 2020 | $107.26M | Apr 22, 2022 |
| FY2021 | Mar 2, 2019 | $96.42M | Apr 22, 2021 |
| FY2019 | Mar 3, 2018 | $127.46M | Apr 24, 2020 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 1, 2025 | $35.59M | Apr 24, 2025 |
| FY2025 | Mar 2, 2024 | $43.18M | Apr 24, 2025 |
| FY2025 | Feb 25, 2023 | $45.18M | Apr 24, 2025 |
| FY2024 | Feb 26, 2022 | $21.84M | Apr 26, 2024 |
| FY2023 | Feb 27, 2021 | $26.17M | Apr 21, 2023 |
| FY2022 | Feb 29, 2020 | $51.43M | Apr 22, 2022 |
| FY2021 | Mar 2, 2019 | $60.72M | Apr 22, 2021 |
| FY2019 | Mar 3, 2018 | $53.20M | Apr 24, 2020 |
| FY2018 | Mar 4, 2017 | $68.06M | Apr 26, 2019 |
| FY2017 | Feb 27, 2016 | $42.04M | Apr 30, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 1, 2025 | $1.18B | Apr 24, 2025 |
| FY2025 | Mar 2, 2024 | $884.06M | Apr 24, 2025 |
| FY2025 | Feb 25, 2023 | $915.37M | Apr 24, 2025 |
| FY2024 | Feb 26, 2022 | $887.86M | Apr 26, 2024 |
| FY2023 | Feb 27, 2021 | $1.02B | Apr 21, 2023 |
| FY2022 | Feb 29, 2020 | $1.13B | Apr 22, 2022 |
| FY2021 | Mar 2, 2019 | $1.07B | Apr 22, 2021 |
| FY2019 | Mar 3, 2018 | $1.02B | Apr 24, 2020 |
| FY2018 | Mar 4, 2017 | $784.66M | Apr 26, 2019 |
| FY2017 | Feb 27, 2016 | $657.44M | Apr 30, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 1, 2025 | $487.90M | Apr 24, 2025 |
| FY2025 | Mar 2, 2024 | $471.03M | Apr 24, 2025 |
| FY2025 | Feb 25, 2023 | $396.41M | Apr 24, 2025 |
| FY2025 | Feb 26, 2022 | $386.20M | Apr 24, 2025 |
| FY2024 | Feb 27, 2021 | $492.75M | Apr 26, 2024 |
| FY2023 | Feb 29, 2020 | $516.78M | Apr 21, 2023 |
| FY2022 | Mar 2, 2019 | $496.32M | Apr 22, 2022 |
| FY2021 | Mar 3, 2018 | $511.36M | Apr 22, 2021 |
| FY2019 | Mar 4, 2017 | $470.58M | Apr 24, 2020 |
| FY2016 | Feb 27, 2016 | $406.20M | Apr 28, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 1, 2025 | $235.78M | Apr 24, 2025 |
| FY2025 | Mar 2, 2024 | $129.18M | Apr 24, 2025 |
| FY2025 | Feb 25, 2023 | $129.03M | Apr 24, 2025 |
| FY2024 | Feb 26, 2022 | $130.10M | Apr 26, 2024 |
| FY2023 | Feb 27, 2021 | $130.10M | Apr 21, 2023 |
| FY2022 | Feb 29, 2020 | $185.52M | Apr 22, 2022 |
| FY2021 | Mar 2, 2019 | $185.83M | Apr 22, 2021 |
| FY2019 | Mar 3, 2018 | $180.96M | Apr 24, 2020 |
| FY2018 | Mar 4, 2017 | $101.33M | Apr 26, 2019 |
| FY2017 | Feb 27, 2016 | $74.00M | Apr 30, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 1, 2025 | $359.98M | Apr 24, 2025 |
| FY2025 | Mar 2, 2024 | $340.38M | Apr 24, 2025 |
| FY2024 | Feb 25, 2023 | $273.74M | Apr 26, 2024 |
| FY2023 | Feb 26, 2022 | $254.83M | Apr 21, 2023 |
| FY2022 | Feb 27, 2021 | $357.24M | Apr 22, 2022 |
| FY2021 | Feb 29, 2020 | $388.01M | Apr 22, 2021 |
| FY2019 | Mar 2, 2019 | $367.60M | Apr 24, 2020 |
| FY2018 | Mar 3, 2018 | $373.26M | Apr 26, 2019 |
| FY2017 | Mar 4, 2017 | $342.00M | Apr 30, 2018 |
| FY2016 | Feb 27, 2016 | $282.48M | Apr 28, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 1, 2025 | $41.45M | Apr 24, 2025 |
| FY2025 | Mar 2, 2024 | $37.22M | Apr 24, 2025 |
| FY2024 | Feb 25, 2023 | $19.92M | Apr 26, 2024 |
| FY2023 | Feb 26, 2022 | $37.58M | Apr 21, 2023 |
| FY2022 | Feb 27, 2021 | $47.28M | Apr 22, 2022 |
| FY2021 | Feb 29, 2020 | $14.95M | Apr 22, 2021 |
| FY2019 | Mar 2, 2019 | $17.09M | Apr 24, 2020 |
| FY2018 | Mar 3, 2018 | $19.36M | Apr 26, 2019 |
| FY2017 | Mar 4, 2017 | $19.46M | Apr 30, 2018 |
| FY2017 | Feb 27, 2016 | $60.47M | Apr 30, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 1, 2025 | $285.00M | Apr 24, 2025 |
| FY2024 | Mar 2, 2024 | $62.00M | Apr 26, 2024 |
| FY2023 | Feb 25, 2023 | $169.84M | Apr 21, 2023 |
| FY2022 | Feb 26, 2022 | $163.00M | Apr 22, 2022 |
| FY2021 | Feb 27, 2021 | $165.00M | Apr 22, 2021 |
| FY2019 | Feb 29, 2020 | $217.90M | Apr 24, 2020 |
| FY2018 | Mar 2, 2019 | $245.85M | Apr 26, 2019 |
| FY2017 | Mar 3, 2018 | $215.98M | Apr 30, 2018 |
| FY2016 | Mar 4, 2017 | $65.40M | Apr 28, 2017 |
| FY2015 | Feb 27, 2016 | $20.40M | Apr 25, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 1, 2025 | 3 | Apr 24, 2025 |
| FY2025 | Mar 2, 2024 | 4 | Apr 24, 2025 |
| FY2025 | Feb 25, 2023 | 4 | Apr 24, 2025 |
| FY2024 | Feb 26, 2022 | 0 | Apr 26, 2024 |
| FY2023 | Feb 27, 2021 | 0 | Apr 21, 2023 |
| FY2019 | Feb 29, 2020 | 0 | Apr 24, 2020 |
| FY2019 | Nov 30, 2019 | 0 | Apr 24, 2020 |
| FY2019 | Aug 31, 2019 | 0 | Apr 24, 2020 |
| FY2019 | Jun 1, 2019 | 0 | Apr 24, 2020 |
| FY2019 | Mar 2, 2019 | 0 | Apr 24, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 1, 2025 | 3 | Apr 24, 2025 |
| FY2025 | Mar 2, 2024 | 4 | Apr 24, 2025 |
| FY2025 | Feb 25, 2023 | 4 | Apr 24, 2025 |
| FY2024 | Feb 26, 2022 | 0 | Apr 26, 2024 |
| FY2023 | Feb 27, 2021 | 0 | Apr 21, 2023 |
| FY2019 | Feb 29, 2020 | 0 | Apr 24, 2020 |
| FY2019 | Nov 30, 2019 | 0 | Apr 24, 2020 |
| FY2019 | Aug 31, 2019 | 0 | Apr 24, 2020 |
| FY2019 | Jun 1, 2019 | 0 | Apr 24, 2020 |
| FY2019 | Mar 2, 2019 | 0 | Apr 24, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 1, 2025 | 21.42M | Apr 24, 2025 |
| FY2025 | Mar 2, 2024 | 22.09M | Apr 24, 2025 |
| FY2024 | Feb 25, 2023 | 22.22M | Apr 26, 2024 |
| FY2023 | Feb 26, 2022 | 23.70M | Apr 21, 2023 |
| FY2022 | Feb 27, 2021 | 25.71M | Apr 22, 2022 |
| FY2021 | Feb 29, 2020 | 26.44M | Apr 22, 2021 |
| FY2019 | Mar 2, 2019 | 27.02M | Apr 24, 2020 |
| FY2018 | Mar 3, 2018 | 28.16M | Apr 26, 2019 |
| FY2017 | Mar 4, 2017 | 28.68M | Apr 30, 2018 |
| FY2016 | Feb 27, 2016 | 28.68M | Apr 28, 2017 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 1, 2025 | $21.74M | Apr 24, 2025 |
| FY2025 | Mar 2, 2024 | $21.13M | Apr 24, 2025 |
| FY2025 | Feb 25, 2023 | $19.67M | Apr 24, 2025 |
| FY2024 | Feb 26, 2022 | $20.27M | Apr 26, 2024 |
| FY2023 | Feb 27, 2021 | $19.60M | Apr 21, 2023 |
| FY2022 | Feb 29, 2020 | $18.71M | Apr 22, 2022 |
| FY2021 | Mar 2, 2019 | $17.86M | Apr 22, 2021 |
| FY2019 | Mar 3, 2018 | $16.39M | Apr 24, 2020 |
| FY2018 | Mar 4, 2017 | $14.67M | Apr 26, 2019 |
| FY2017 | Feb 27, 2016 | $13.18M | Apr 30, 2018 |